These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24447562)

  • 1. [Pathology of mammary mucinous carcinoma and its molecular markers].
    Zhang W; Niu Y; Zhang TX; Liu S; Liu F
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):777-9. PubMed ID: 24447562
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
    Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
    Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas.
    Adsay NV; Merati K; Nassar H; Shia J; Sarkar F; Pierson CR; Cheng JD; Visscher DW; Hruban RH; Klimstra DS
    Am J Surg Pathol; 2003 May; 27(5):571-8. PubMed ID: 12717243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous carcinoma of the breast: a multifaceted study with special reference to histogenesis and neuroendocrine differentiation.
    Kato N; Endo Y; Tamura G; Katayama Y; Motoyama T
    Pathol Int; 1999 Nov; 49(11):947-55. PubMed ID: 10594840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of the most severely dysplastic/invasive lesions and mucin phenotypes in intraductal papillary mucinous neoplasm of the pancreas.
    Karasaki H; Mizukami Y; Tokusashi Y; Koizumi K; Ishizaki A; Imai K; Yoshikawa D; Kino S; Sasajima J; Tanno S; Matsumoto K; Miyokawa N; Kono T; Kohgo Y; Furukawa H
    Pancreas; 2011 May; 40(4):588-94. PubMed ID: 21441843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of mammary carcinoma.
    Perez-Mesa CM
    Major Probl Clin Surg; 1967; 5():70-87. PubMed ID: 4351551
    [No Abstract]   [Full Text] [Related]  

  • 7. Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion.
    Gadre SA; Perkins GH; Sahin AA; Sneige N; Deavers MT; Middleton LP
    Histopathology; 2008 Nov; 53(5):545-53. PubMed ID: 18983463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors.
    Xu Y; Kimura N; Yoshida R; Lin H; Yoshinaga K
    Oncol Rep; 2001; 8(5):1177-82. PubMed ID: 11496338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.
    Kim D; Jung WH; Koo JS
    Pathobiology; 2012; 79(3):144-53. PubMed ID: 22269464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous lesions of the breast. A pathological continuum.
    Weaver MG; Abdul-Karim FW; al-Kaisi N
    Pathol Res Pract; 1993 Sep; 189(8):873-6. PubMed ID: 8302709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2-positivity in mucinous cancer might be related to accompanying infiltrating ductal carcinoma histology.
    Altundag K
    Breast Cancer Res Treat; 2020 Apr; 180(3):829. PubMed ID: 32162191
    [No Abstract]   [Full Text] [Related]  

  • 12. The mucinous variant of columnar cell lesions.
    Verschuur-Maes AH; Van Diest PJ
    Histopathology; 2011 May; 58(6):847-53. PubMed ID: 21585423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between solid papillary carcinoma and associated invasive carcinoma according to expression of WT1 and several MUCs.
    Oh EJ; Koo JS; Kim JY; Jung WH
    Pathol Res Pract; 2014 Dec; 210(12):953-8. PubMed ID: 25204785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can mucinous lesions of the breast be reliably diagnosed by core needle biopsy?
    Renshaw AA
    Am J Clin Pathol; 2002 Jul; 118(1):82-4. PubMed ID: 12109860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carcinoma of the female breast. Morphological aspects].
    Silva JN
    Arq Patol; 1972 Aug; 43(2):109-20. PubMed ID: 4343609
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucocelelike tumor of the breast associated with atypical ductal hyperplasia or mucinous carcinoma. A clinicopathologic study of seven cases.
    Ro JY; Sneige N; Sahin AA; Silva EG; del Junco GW; Ayala AG
    Arch Pathol Lab Med; 1991 Feb; 115(2):137-40. PubMed ID: 1847035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast neoplasms: histological classification].
    Sakamoto G
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():54-9. PubMed ID: 17682139
    [No Abstract]   [Full Text] [Related]  

  • 18. Precursor lesions of mucinous carcinoma of the breast: analysis of 130 cases.
    Kryvenko ON; Chitale DA; Yoon J; Arias-Stella J; Meier FA; Lee MW
    Am J Surg Pathol; 2013 Jul; 37(7):1076-84. PubMed ID: 23759933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
    Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.